Pentosan Polysulfate in Treating Patients With Gastrointestinal Disturbance Caused by Radiation Therapy
Completed
National Cancer Institute (NCI)
Phase 3
1999-06-01
RATIONALE: Pentosan polysulfate may be effective in treating side effects of radiation
therapy to the abdomen or pelvis. It is not yet known whether pentosan polysulfate is more
effective than no further therapy for treating gastrointestinal disturbance caused by
previous radiation therapy.
PURPOSE: Randomized phase III trial to determine the effectiveness of pentosan polysulfate in
treating patients who have inflammation of the rectum, diarrhea, or blood in stools caused by
previous radiation therapy to the abdomen and pelvis.
Pentosan Polysulfate in Treating Patients With Gastrointestinal Disturbance Caused by Radiation Therapy
Completed
Radiation Therapy Oncology Group
Phase 3
1999-06-01
RATIONALE: Pentosan polysulfate may be effective in treating side effects of radiation
therapy to the abdomen or pelvis. It is not yet known whether pentosan polysulfate is more
effective than no further therapy for treating gastrointestinal disturbance caused by
previous radiation therapy.
PURPOSE: Randomized phase III trial to determine the effectiveness of pentosan polysulfate in
treating patients who have inflammation of the rectum, diarrhea, or blood in stools caused by
previous radiation therapy to the abdomen and pelvis.
Effectiveness and Safety Study of Pentosan Polysulfate Sodium for the Treatment of Interstitial Cystitis
Terminated
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Phase 4
2003-09-01
The purpose of this study is to evaluate the safety and effectiveness of pentosan polysulfate
sodium 100 mg once a day, pentosan polysulfate sodium 100 mg three times a day, and placebo
for 24 weeks for the relief of bladder pain or discomfort associated with interstitial
cystitis.
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.
